Observational studies play an essential role in medical research. They help researchers investigate disease patterns, identify potential risk factors, evaluate health outcomes, and understand associations between exposures and clinical conditions. However, the value of an observational study depends not only on its design and findings but also on how clearly its methods and results are reported.

The STROBE checklist provides a structured framework for reporting observational research. STROBE stands for Strengthening the Reporting of Observational Studies in Epidemiology. It helps researchers ensure that important information about their study is communicated transparently, from the research objectives and participant selection to statistical analysis, limitations, and interpretation.

For medical students, postgraduate scholars, epidemiologists, clinical researchers, and authors preparing journal submissions, understanding the STROBE checklist can make manuscript preparation more systematic. This guide explains the checklist, its 22 items, its application to different observational study designs, and the common reporting mistakes researchers should avoid in 2026.

What Is the STROBE Checklist?

The STROBE checklist is a reporting guideline developed to improve the transparency and completeness of observational research publications. It was developed for three major analytical study designs:

  • Cohort studies
  • Case-control studies
  • Cross-sectional studies

The checklist contains 22 items covering the title and abstract, introduction, methods, results, and discussion. Most items apply across all three study designs, while some recommendations vary according to the design being reported. The official STROBE guidance and the EQUATOR Network overview provide the relevant checklists and supporting information.

Why Is STROBE Important in Medical Research?

A research article may contain useful data but still be difficult to assess if the authors omit essential methodological details. Readers need to know how participants were selected, how variables were measured, how missing information was handled, and whether the reported conclusions are justified by the findings.

The STROBE checklist helps authors:

  • Improve the completeness of research reporting
  • Explain study design and participant selection clearly
  • Describe potential sources of bias and confounding
  • Report statistical methods and estimates transparently
  • Identify limitations that may influence interpretation
  • Prepare manuscripts for journal submission and peer review

Important distinction: STROBE is a reporting guideline, not a tool for designing a study or assigning a numerical quality score. Following it does not automatically establish that a study is methodologically sound, free from bias, or suitable for clinical decision-making.

Understanding the Three Observational Study Designs Covered by STROBE

Before using the checklist, identify the study design. The appropriate participant information, outcome reporting, and analytical details depend on the type of investigation.

1. Cohort Studies

Cohort studies examine groups of individuals according to their exposure status and assess outcomes over time or through existing records. They may be prospective or retrospective.

For example, researchers might investigate whether adults with a particular occupational exposure have a higher incidence of respiratory disease than adults without that exposure.

When reporting a cohort study, authors should explain participant eligibility, exposure classification, follow-up procedures, outcome ascertainment, loss to follow-up, and the analysis of outcomes over time.

2. Case-Control Studies

Case-control studies select participants according to their outcome status. Researchers compare individuals with a condition or outcome (cases) with individuals without it (controls) to investigate prior exposures.

For example, a study might compare previous smoking exposure among patients diagnosed with a specific disease and a suitable control group.

Authors should describe how cases were identified, how controls were selected, why the control group was appropriate, and whether matching was used.

3. Cross-Sectional Studies

Cross-sectional studies examine exposures and outcomes in a defined population at a particular point or during a specified period.

For example, researchers might estimate the prevalence of hypertension among adults attending primary healthcare centres.

The report should explain how participants were selected, how variables were measured, and how the sampling strategy was considered in the statistical analysis.

Cross-sectional studies can identify associations, but they often cannot establish whether an exposure preceded an outcome. Authors should avoid making causal claims that the design cannot support.

Medical Journal IMJ Health Call for Papers

The 22 STROBE Checklist Items Explained

The official STROBE checklist organizes its recommendations into six major areas. The following guide summarizes the purpose of each item in practical language. Consult the official checklist for the complete recommendations and design-specific wording.

Section A: Title and Abstract

Item 1: Title and abstract

Identify the study design using a commonly understood term in the title or abstract. Provide an informative, balanced abstract describing what was investigated, how it was studied, and what was found.

For example, a title may identify a study as a retrospective cohort study or a cross-sectional survey. Use the term only if it accurately describes the research design.

The abstract should summarize the research without exaggerating the importance of the findings or omitting material limitations.

Section B: Introduction

Item 2: Background and rationale

Explain the scientific background, relevant existing evidence, and reason the study was necessary.

A strong introduction identifies the research problem and the knowledge gap the investigation seeks to address. It should establish the context without making unsupported claims about what the study will prove.

Item 3: Objectives

State the specific objectives and any prespecified hypotheses.

For example, a study might aim to estimate the prevalence of hypertension among adults in a defined population or investigate the association between a particular exposure and disease incidence.

Clearly stated objectives help readers assess whether the methods and reported findings address the research question.

Section C: Methods

Item 4: Study design

Present the essential features of the study design early in the Methods section.

State whether the study is a cohort, case-control, or cross-sectional investigation. Include relevant design details, such as whether the study is prospective or retrospective when applicable.

Item 5: Setting

Describe the study location, setting, and relevant dates.

Include the recruitment period, exposure period, follow-up period, and data collection dates where applicable. These details help readers understand the circumstances in which the research was conducted.

Item 6: Participants

Explain eligibility criteria and how participants were identified and selected.

The details vary by design:

  • Cohort study: Explain participant selection, exposure groups, and follow-up methods.
  • Case-control study: Describe case identification, control selection, and the rationale for the control group.
  • Cross-sectional study: Explain the sampling frame, eligibility criteria, and participant selection.

For matched studies, report the matching criteria and relevant group numbers.

Item 7: Variables

Define the outcomes, exposures, predictors, potential confounders, and effect modifiers.

If diagnostic criteria or classification thresholds were used, explain them. Clear definitions allow readers to understand precisely what the researchers measured and how the variables were categorized.

Item 8: Data sources and measurement

Identify the data sources and explain how each important variable was assessed.

For example, specify whether information came from electronic health records, laboratory tests, clinical examinations, structured questionnaires, or participant interviews.

If different groups were assessed using different methods, explain how comparability was addressed.

Item 9: Bias

Describe the steps taken to address potential sources of bias.

Relevant concerns may include selection bias, information bias, measurement error, recall bias, and loss to follow-up. Explain the measures actually used to reduce these risks.

Do not claim that bias was eliminated merely because a control procedure was included.

Item 10: Study size

Explain how the study size was determined.

Describe the sample size calculation, precision target, power assumptions, available population, or other rationale used. If the sample consisted of all eligible records available during a specified period, state that accurately.

Item 11: Quantitative variables

Explain how continuous or quantitative variables were handled in the analysis.

If values were categorized into groups, state the category boundaries and explain why those cutoffs were chosen. Avoid arbitrary categorization without justification, especially when it discards meaningful information.

Item 12: Statistical methods

Describe the statistical methods used to analyze the data.

Include relevant information about:

  • Methods for controlling confounding
  • Subgroup and interaction analyses
  • Handling missing data
  • Loss to follow-up in cohort studies
  • Matching in case-control studies
  • Sampling strategies in cross-sectional studies
  • Sensitivity analyses, where performed

Identify the statistical methods and relevant software details necessary to understand the analysis. Explain important analytical choices rather than simply naming a software package.

Section D: Results

Item 13: Participants

Report the number of individuals at each important stage of the study.

This may include the number assessed for eligibility, enrolled, included in the analysis, followed up, and analyzed. Explain reasons for non-participation where available and consider using a flow diagram.

Item 14: Descriptive data

Present relevant participant characteristics, exposures, and potential confounders.

Report the number of participants with missing data for each important variable. In cohort studies, summarize follow-up time where applicable.

Tables are often useful for presenting demographic and clinical characteristics in a readable format.

Item 15: Outcome data

Report the outcome information relevant to the study design.

  • Cohort study: Present outcome events or appropriate summary measures over time.
  • Case-control study: Report the number of participants in each exposure category or relevant exposure summaries.
  • Cross-sectional study: Present outcome counts or summary measures, such as prevalence estimates where appropriate.

The reported outcome information should correspond to the objectives and analysis described in the Methods section.

Item 16: Main results

Present unadjusted estimates and, where appropriate, adjusted estimates with measures of precision, such as 95% confidence intervals.

Explain which confounders were adjusted for and why they were included. If quantitative variables were categorized, report the category boundaries. Where useful and appropriate, consider presenting relative risk estimates alongside absolute risks over a meaningful time period.

Avoid presenting p-values alone when effect estimates and confidence intervals are needed to interpret the findings.

Item 17: Other analyses

Report additional analyses, including subgroup analyses, interaction analyses, and sensitivity analyses.

Distinguish analyses that were prespecified from exploratory analyses conducted after reviewing the data. Explain the purpose of important additional analyses and interpret their findings cautiously.

Section E: Discussion

Item 18: Key results

Summarize the main findings in relation to the study objectives.

Focus on the most important results and explain how they answer the original research questions without repeating every number from the Results section.

Item 19: Limitations

Discuss the limitations of the study, including possible sources of bias, imprecision, measurement error, and other weaknesses that could affect interpretation.

Explain the likely direction and potential magnitude of important biases when these can reasonably be assessed. Avoid generic statements such as "the study had limitations" without explaining what they were.

Item 20: Interpretation

Provide a cautious overall interpretation that considers the objectives, limitations, multiple analyses, relevant evidence, and study design.

Do not infer causation from an association alone. Explain uncertainty and avoid overstating the clinical implications of observational findings.

Item 21: Generalisability

Discuss the extent to which the findings may apply to other populations, healthcare settings, or circumstances.

Consider the study population, selection methods, clinical environment, and other factors that may influence applicability. Generalisability should be justified rather than assumed.

Section F: Other Information

Item 22: Funding

Report the source of funding and the role of funders in the study, where applicable. If relevant, explain whether funders influenced the study design, data collection, analysis, interpretation, or manuscript preparation.

Disclose funding and other required interests transparently, following journal policies.

How to Use the STROBE Checklist Before Journal Submission

Using STROBE is most effective when it is integrated into manuscript preparation rather than treated as a last-minute form.

Step 1: Identify the study design. Confirm whether the manuscript reports a cohort, case-control, or cross-sectional study. Choose the corresponding official checklist.

Step 2: Review the manuscript section by section. Compare the title, abstract, introduction, methods, results, discussion, and funding information with the checklist.

Step 3: Locate the supporting information. For each item, identify where the relevant information appears in the manuscript. If a required detail is missing, revise the manuscript rather than simply marking the item complete.

Step 4: Check design-specific requirements. Verify that the report addresses issues specific to the study design, such as follow-up and loss to follow-up in cohort studies or case and control selection in case-control studies.

Step 5: Verify numerical consistency. Check sample sizes, denominators, missing-data counts, effect estimates, confidence intervals, and other values against the final dataset and statistical output.

Step 6: Complete the journal's checklist requirements. Some journals request a completed checklist with manuscript page or section references. Follow the target journal's instructions and ensure that each reference points to the correct location.

The official STROBE checklist page provides combined and study-specific versions in Word and PDF formats.

Example: Applying STROBE to a Cross-Sectional Medical Study

Imagine a hypothetical study estimating the prevalence of hypertension among adults attending primary healthcare centres.

The researchers could use the STROBE checklist to check whether the manuscript:

  • Identifies the study as cross-sectional in the title or abstract
  • Explains why estimating hypertension prevalence is important
  • States the study objectives clearly
  • Describes the healthcare centres and data collection period
  • Explains participant eligibility and selection
  • Defines hypertension using the criteria actually applied
  • Describes how blood pressure was measured
  • Reports steps taken to address possible selection or measurement bias
  • Explains the sample size rationale
  • Describes statistical methods, including any adjustment for confounders
  • Reports participant numbers and missing data
  • Presents prevalence estimates with appropriate uncertainty
  • Discusses limitations, including potential selection bias and limits on generalisability
  • Reports funding and the role of funders where applicable

This example illustrates how the checklist can be applied to a manuscript. It does not represent actual study findings or a substitute for the full official checklist.

Common Mistakes When Using the STROBE Checklist

Treating STROBE as a study-quality score

STROBE is intended to improve reporting completeness. A completed checklist does not prove that the study design was appropriate or that the findings are reliable.

Choosing the wrong checklist

The reporting requirements vary by design. A cohort study, case-control study, and cross-sectional study do not require identical participant and outcome descriptions.

Marking items complete without sufficient detail

Mentioning a statistical test without explaining its role, or stating that bias was considered without describing the steps taken, may leave important questions unanswered.

Ignoring missing data

Authors should report missing information and explain how it was handled. Omitting missing-data details can make it difficult to assess potential bias.

Overstating causal relationships

Observational findings may demonstrate associations without establishing causation. Interpret results in light of the study design and potential confounding.

Forgetting to discuss limitations

A strong report acknowledges weaknesses and explains how they affect interpretation. Limitations should be specific to the study rather than presented as a generic paragraph.

Completing the checklist only after the paper is finalized

Although a checklist can be used during final review, applying it earlier helps researchers identify reporting gaps before submission.

STROBE vs. Other Medical Research Reporting Guidelines

STROBE is not suitable for every type of medical research. Other reporting guidelines address different designs and purposes.

STROBE: Observational studies.

CONSORT: Randomized controlled trials.

PRISMA: Systematic reviews and meta-analyses.

STARD: Diagnostic accuracy studies.

CARE: Case reports.

ARRIVE: Animal research.

TRIPOD: Clinical prediction model studies.

SPIRIT: Clinical trial protocols.

A study may require a specialized guideline or extension depending on its subject and methodology. The EQUATOR Network is a useful resource for identifying relevant reporting guidelines.

Always verify the current requirements of the target journal, as editorial instructions may specify a particular checklist, version, or submission format.

Final STROBE Submission Checklist for Researchers

Before submitting an observational medical research article, confirm that:

  • The study design is clearly identified
  • The research background and objectives are explained
  • The setting, dates, and participant selection methods are described
  • Variables and measurement procedures are clearly defined
  • Potential sources of bias are addressed
  • The sample size rationale is reported
  • Statistical methods and confounder adjustments are explained
  • Participant numbers and missing data are reported
  • Main results include appropriate estimates and measures of precision
  • Additional analyses are described accurately
  • Limitations and generalisability are discussed
  • Conclusions reflect the evidence and study design
  • Funding and funder involvement are disclosed where applicable
  • The completed checklist matches the manuscript and journal requirements

This checklist is a practical final review aid, not a replacement for the full STROBE document.

The STROBE checklist is an important resource for researchers preparing observational medical research manuscripts. By covering 22 reporting items across the title and abstract, introduction, methods, results, discussion, and other information, it helps authors communicate the research process and findings more transparently.

Its value lies in encouraging complete reporting of participant selection, variable definitions, statistical methods, potential bias, outcome data, limitations, and funding. However, STROBE should be used as a reporting guide rather than as proof of methodological quality or scientific validity.

For medical students, postgraduate scholars, epidemiologists, and clinical researchers, incorporating STROBE into manuscript preparation can make it easier to identify missing details, improve clarity, and prepare a more complete submission. Combining the checklist with sound research methods, accurate data, and careful interpretation supports more transparent and credible medical literature. For those considering doctoral research in this area, Top 10 Pharmaceutical Research Topics for PhD offers guidance on selecting impactful research directions.

Continue Exploring Our Blog